Applied Therapeutics Files 2025 Proxy Statement
| Field | Detail |
|---|---|
| Company | Applied Therapeutics, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: APLT
TL;DR
APLT proxy filed - vote on board & exec pay for FY24.
AI Summary
Applied Therapeutics, Inc. filed a DEF 14A proxy statement on April 28, 2025, for its annual meeting on June 9, 2025. The filing details executive compensation, board member elections, and other corporate governance matters for the fiscal year ending December 31, 2024. Key individuals mentioned include Shoshana Shendelman and John Johnson, who are members of the board.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in corporate governance decisions.
Risk Assessment
Risk Level: low — This is a standard DEF 14A filing for annual shareholder meeting matters and does not contain new material financial or operational information.
Key Numbers
- 20250609 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 2024-12-31 — Fiscal Year End (The proxy statement covers matters related to this fiscal year.)
Key Players & Entities
- Applied Therapeutics, Inc. (company) — Registrant
- Shoshana Shendelman (person) — Board Member
- John Johnson (person) — Board Member
- Les Funtleyder (person) — Board Member
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on June 9, 2025, including details on director elections, executive compensation, and other corporate governance matters for the fiscal year ending December 31, 2024.
Who are the key individuals mentioned in relation to the board?
Shoshana Shendelman, John Johnson, and Les Funtleyder are mentioned as members of the board.
When was this filing submitted to the SEC?
This filing was submitted on April 28, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's state of incorporation?
Applied Therapeutics, Inc. is incorporated in Delaware (DE).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 by Shoshana Shendelman regarding Applied Therapeutics, Inc..